Koch Institute 2019 Immune Engineering Symposium
January 28-29, 2019, 8AM – 4PM
Kresge Auditorium, MIT
Biological, chemical, and materials engineers are engaged at the forefront of immunology research. At their disposal is an analytical toolkit honed to solve problems in the petrochemical and materials industries, which share the presence of complex reaction networks, and convective and diffusive molecular transport. Powerful synthetic capabilities have also been crafted: binding proteins can be engineered with effectively arbitrary specificity and affinity, and multifunctional nanoparticles and gels have been designed to interact in highly specific fashions with cells and tissues. Fearless pursuit of knowledge and solutions across disciplinary boundaries characterizes this nascent discipline of immune engineering, synergizing with immunologists and clinicians to put immunotherapy into practice.
The 2019 symposium will include two poster sessions and four abstract-selected talks. Abstract submission deadline is December 22, 2018. Registration closes December 23rd.
Featuring:
Facundo Batista (Ragon Institute)
Michael Birnbaum (MIT, Koch Institute)
Bryan Bryson (MIT, Department of Biological Engineering)
Yvonne Chen (University of California, Los Angeles)
Stephanie Dougan (Dana-Farber Cancer Institute)
Glenn Dranoff (Novartis Institute for Biomedical Research)
Michael Dustin (University of Oxford)
Phil Greenberg (Fred Hutchinson Cancer Research Center)
Darrell Irvine (MIT, Koch Institute; HHMI)
Tyler Jacks (MIT, Koch Institute; HHMI)
Max Krummel (University of California, San Francisco)
Diane Mathis (Harvard Medical School)
Mikael Pittet (Massachusetts General Hospital)
Aviv Regev (Broad Institute; Koch Institute)
Bob Schreiber (Wash University of St. Louis)
Alex Shalek (MIT, Department of Chemistry, Koch Institute)
Jamie Spangler (John Hopkins University)
Stefani Spranger (MIT, Koch Institute)
Tim Springer (Boston Children’s Hospital)
Melody Swartz (University of Chicago)
Cathy Wu (Massachusetts General Hospital)
Biological, chemical, and materials engineers are engaged at the forefront of immunology research. At their disposal is an analytical toolkit honed to solve problems in the petrochemical and materials industries, which share the presence of complex reaction networks, and convective and diffusive molecular transport. Powerful synthetic capabilities have also been crafted: binding proteins can be engineered with effectively arbitrary specificity and affinity, and multi functional nanoparticles and gels have been designed to interact in highly specific fashions with cells and tissues. Fearless pursuit of knowledge and solutions across disciplinary boundaries characterizes this nascent discipline of immune engineering, synergizing with immunologists and clinicians to put immunotherapy into practice.
Leave a Reply